Bayer, J&J Botched Xarelto Bleeding Warning, Pa. Jury Told
By Matt Fair ( April 6, 2018, 7:28 PM EDT) -- A second trial over internal bleeding allegedly linked to the anticoagulant Xarelto kicked off in Philadelphia on Friday as jurors heard arguments that a pair of Bayer AG and Johnson & Johnson units failed to warn doctors about the risk the medication posed when used in combination with other drugs....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.